Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
JCI - Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response
Considerations for cancer immunotherapy biomarker research during COVID-19 in: Endocrine-Related Cancer Volume 27 Issue 9 (2020)
Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort | BMC Infectious Diseases | Full Text
T-cell activation without proliferation in juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text
Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis - ScienceDirect
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
JCI Insight - Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency | SpringerLink
Cortisol Patterns Are Associated with T Cell Activation in HIV | PLOS ONE
Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications
T-Cell Activation | Sartorius
TAMs may be friends, not foes, in early-stage tumor T cell response
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor - ScienceDirect
JoF | Free Full-Text | Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis
Frequency of activated CD4+ T cells across HIV-1 disease states. CD38... | Download Scientific Diagram
CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART | Journal of Translational Medicine | Full Text
Frontiers | Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection
Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
What does HLA-DR expression on CD4 T cells indicate? | Immunopaedia
Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine
Early (CD69) and late (HLA-DR) activation marker expression by T cells... | Download Scientific Diagram
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications
HLA-DR Alpha 2 Mediates Negative Signalling via Binding to Tirc7 Leading to Anti-Inflammatory and Apoptotic Effects in Lymphocytes In Vitro and In Vivo | PLOS ONE
